Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6441674B2 - Aqueous liquid beverage - Google Patents
[go: Go Back, main page]

JP6441674B2 - Aqueous liquid beverage - Google Patents

Aqueous liquid beverage Download PDF

Info

Publication number
JP6441674B2
JP6441674B2 JP2014509183A JP2014509183A JP6441674B2 JP 6441674 B2 JP6441674 B2 JP 6441674B2 JP 2014509183 A JP2014509183 A JP 2014509183A JP 2014509183 A JP2014509183 A JP 2014509183A JP 6441674 B2 JP6441674 B2 JP 6441674B2
Authority
JP
Japan
Prior art keywords
aqueous liquid
peptide
pectin
mass
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014509183A
Other languages
Japanese (ja)
Other versions
JPWO2013151084A1 (en
Inventor
隆史 堂本
隆史 堂本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2014509183A priority Critical patent/JP6441674B2/en
Publication of JPWO2013151084A1 publication Critical patent/JPWO2013151084A1/en
Application granted granted Critical
Publication of JP6441674B2 publication Critical patent/JP6441674B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231Pectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

本発明は、水性の液体飲料に関し、医薬品、医薬部外品及び食品等の分野において利用されうる。   The present invention relates to an aqueous liquid beverage and can be used in the fields of pharmaceuticals, quasi drugs, foods and the like.

肥満はメタボリックシンドロームに至る深刻な社会問題である。肥満を予防するための有効な手段としては、食事摂取量を制限してのダイエットが挙げられるが、これによって生じる空腹感のため、長続きしないというのが実状であった。そこで、空腹感を解消するために、香料又は香料化合物を主成分とする空腹感緩和剤(特許文献1参照)、シリアル食品(特許文献2参照)、可食性リンタンパクと金属の炭酸塩(特許文献3参照)などが提供されている。   Obesity is a serious social problem that leads to metabolic syndrome. An effective means for preventing obesity is a diet with a limited dietary intake, but the actual situation is that it does not last long because of the feeling of hunger. Therefore, in order to eliminate the feeling of hunger, the hunger sensation relieving agent (see Patent Document 1), a cereal food (see Patent Document 2), an edible phosphoprotein, and a metal carbonate (Patent) Reference 3) is provided.

そうした空腹感を改善するための方法の1つとして、寒天を用い、胃液に一定時間浸された後の寒天のゲル強度を向上させる方法(特許文献4参照)が報告されている。しかしながら、固いゲルを咀嚼して飲みこむ必要があるため、実用性が高いとは言いがたい。また、ゲル化剤を含む胃内ラフト組成物を用いる方法(特許文献5参照)も報告されているが、ゲルの強度が低く、空腹感を長時間抑制するには至っていない。更に、アミノ酸、タウリン、カルニチン、ペプチド、タンパク質などの栄養成分を同時配合するとゲル強度が低下するという課題があった。   As one method for improving such a feeling of hunger, a method has been reported in which agar is used to improve the gel strength of agar after being immersed in gastric juice for a certain period of time (see Patent Document 4). However, since it is necessary to chew and swallow a hard gel, it is difficult to say that it is highly practical. Moreover, although the method (refer patent document 5) using the gastric raft composition containing a gelatinizer is also reported, the intensity | strength of a gel is low and it has not led to suppressing a feeling of hunger for a long time. Furthermore, when nutritional components such as amino acids, taurine, carnitine, peptides, and proteins are simultaneously blended, there is a problem that gel strength decreases.

特開2008−7427号公報JP 2008-7427 A 特開2007−53929号公報JP 2007-53929 A 特開2010−94085号公報JP 2010-94085 A 特開2008−110923号公報JP 2008-110923 A 特表2009−530254号公報Special table 2009-530254 gazette

本発明の目的は、飲む前は普通の水性液体飲料であるが、飲んだ後に胃の中で胃酸と反応してゲル化し、胃の中に滞留して腹持ちがよいという性質を有し、更にアミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合した水性液体飲料を提供することである。   The object of the present invention is that it is a normal aqueous liquid drink before drinking, but after drinking it has the property of reacting with gastric acid in the stomach to gel, staying in the stomach and having a good stomach, It is to provide an aqueous liquid beverage containing amino acids, taurine, carnitine, peptides or proteins.

本発明者は、上記課題を解決するために鋭意検討した結果、デキストリンを同時配合したLMペクチン配合水性液体飲料は、人工胃液(日局第1液)と反応してゲル化し、アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合することによって低下したゲル強度がかなりの程度で回復することを見いだした。   As a result of intensive studies to solve the above-mentioned problems, the present inventor reacted with artificial gastric juice (JP 1st liquid) to gel the LM pectin-containing aqueous liquid drink containing dextrin at the same time, and the amino acids, taurine, It has been found that the reduced gel strength is restored to a considerable extent by incorporation of carnitine, peptide or protein.

かかる知見により得られた本発明の態様は次のとおりである。
(1)LMペクチン、デキストリン、及びアミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合したことを特徴とする水性液体飲料。
(2)アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質の配合量がLMペクチンの1質量部に対して1.5質量部以下である前記(1)の水性液体飲料。
(3)アミノ酸がグリシン又はアルギニンである前記(1)又は(2)の水性液体飲料。
(4)ペプチドが酵母ペプチド又はコラーゲンペプチドである前記(1)又は(2)の水性液体飲料。
(5)タンパク質がプロティナーゼインヒビターである前記(1)又は(2)の水性液体飲料。
(6)pHが3.5〜7.0である前記(1)〜(5)の何れかの水性液体飲料。
The embodiments of the present invention obtained from such findings are as follows.
(1) An aqueous liquid beverage comprising LM pectin, dextrin, and amino acids, taurine, carnitine, peptides or proteins.
(2) The aqueous liquid drink according to (1), wherein the compounding amount of amino acid, taurine, carnitine, peptide or protein is 1.5 parts by mass or less with respect to 1 part by mass of LM pectin.
(3) The aqueous liquid drink according to (1) or (2) above, wherein the amino acid is glycine or arginine.
(4) The aqueous liquid drink according to (1) or (2) above, wherein the peptide is a yeast peptide or a collagen peptide.
(5) The aqueous liquid drink according to the above (1) or (2), wherein the protein is a proteinase inhibitor.
(6) The aqueous liquid beverage according to any one of (1) to (5), wherein the pH is 3.5 to 7.0.

本発明により、胃酸と反応してゲル化し、そのゲル強度が高いため、空腹感を解消した状態を長時間維持させることができると考えられる、アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合した水性液体飲料を提供することが可能となった。   According to the present invention, it reacts with gastric acid and gels, and since its gel strength is high, it is thought that it can maintain a state in which the feeling of hunger is eliminated for a long time. It became possible to provide liquid beverages.

「ペクチン」とはα−1,4−結合したポリガラクツロン酸が主成分の水溶性多糖類であり、リンゴや柑橘類から抽出される。本発明のペクチンは、リンゴ由来、柑橘類由来の何れのものであってもよいが、ペクチンの構成糖であってフリーの酸若しくはメチルエステルとして存在するガラクツロン酸がメチルエステルであるものの比率が50%未満の「LMペクチン」であることが必要である。因みに、メチルエステルの比率が50%以上のペクチンをHMペクチンというが、酸性域では可溶性固形分が55%以上でないとゲル化しないため、本発明には適さない。   “Pectin” is a water-soluble polysaccharide composed mainly of α-1,4-linked polygalacturonic acid, and is extracted from apples and citrus fruits. The pectin of the present invention may be derived from apples or citrus fruits, but the proportion of pectin constituting galacturonic acid present as free acid or methyl ester is 50%. Less than “LM pectin”. Incidentally, pectin having a methyl ester ratio of 50% or more is referred to as HM pectin. However, in the acidic region, it does not gel unless the soluble solid content is 55% or more, and is not suitable for the present invention.

LMペクチンの配合量は、水性液体飲料中0.01〜10質量%であり、服用性及び胃中でのゲルの強度という点から、0.1〜3.5質量%がより好ましい。   The compounding quantity of LM pectin is 0.01-10 mass% in an aqueous liquid drink, and 0.1-3.5 mass% is more preferable from the point of taking property and the intensity | strength of the gel in a stomach.

「デキストリン」は、デンプンを酸や酵素で加水分解して製造され、数個のブドウ糖が結合したものである。本発明では、通常のデキストリンの他に難消化性デキストリンを用いることもできる。難消化性デキストリンは、人の消化酵素で加水分解されない難消化性、難吸収性の低カロリー水溶性食物繊維である。   “Dextrin” is produced by hydrolyzing starch with an acid or an enzyme, and is a combination of several glucoses. In the present invention, indigestible dextrin can be used in addition to normal dextrin. Indigestible dextrin is an indigestible, hardly absorbable, low-calorie water-soluble dietary fiber that is not hydrolyzed by human digestive enzymes.

デキストリンの配合量は、LMペクチン1質量部に対して0.1〜300質量部であり、1〜100質量部が好ましい。   The compounding quantity of dextrin is 0.1-300 mass parts with respect to 1 mass part of LM pectin, and 1-100 mass parts is preferable.

「アミノ酸」としては、アスパラギン、アスパラギン酸、アラニン、アルギニン、イソロイシン、グリシン、グルタミン、グルタミン酸、システイン、セリン、チロシン、トリプトファン、トレオニン、バリン、プロリン、ヒスチジン、フェニルアラニン、メチオニン、ロイシン、リジンが挙げられるが、グリシン、アルギニンが好ましい。   Examples of the “amino acid” include asparagine, aspartic acid, alanine, arginine, isoleucine, glycine, glutamine, glutamic acid, cysteine, serine, tyrosine, tryptophan, threonine, valine, proline, histidine, phenylalanine, methionine, leucine, and lysine. Glycine and arginine are preferred.

「タウリン」は、アミノエチルスルホン酸又は2−アミノエタンスルホン酸とも呼ばれ、化学合成により生産される他、牛胆汁、貝類、イカ、タコなど様々な動物から抽出物としても生産されるが、本発明ではどちらも用いることができる。   “Taurine” is also called aminoethylsulfonic acid or 2-aminoethanesulfonic acid, and is produced by chemical synthesis, as well as produced from various animals such as cow bile, shellfish, squid, octopus, Either can be used in the present invention.

「カルニチン」は、γ-トリメチル-β-ヒドロキシブチロベタインとも呼ばれる。「カルニチン」としては、L−カルニチン、DL−カルニチン、及びそれらの塩(塩酸塩、硝酸塩、フマル酸塩、酒石酸塩など)やそれらの類縁化合物(アセチルカルニチン、プロピオニルカルニチンなどのアシルカルニチンなど)などが挙げられ、その中でもL−カルニチンが好ましい。 「ペプチド」としては、酵母ペプチド、コラーゲンペプチド、ミルクペプチド、卵白ペプチド、サーデンペプチド、グルタミンペプチド、グロビンペプチドなどが挙げられ、その中でも酵母ペプチド又はコラーゲンペプチドが好ましい。   “Carnitine” is also called γ-trimethyl-β-hydroxybutyrobetaine. Examples of “carnitine” include L-carnitine, DL-carnitine, and salts thereof (hydrochloride, nitrate, fumarate, tartrate, etc.) and related compounds (acylcarnitine such as acetylcarnitine, propionylcarnitine, etc.), etc. Among them, L-carnitine is preferable. Examples of the “peptide” include yeast peptide, collagen peptide, milk peptide, egg white peptide, sadden peptide, glutamine peptide, globin peptide, etc. Among them, yeast peptide or collagen peptide is preferable.

「タンパク質」としては、大豆タンパク質、ミルクタンパク質、小麦タンパク質、米糠タンパク質抽出物、プロティナーゼインヒビターなどが挙げられ、その中でもプロティナーゼインヒビターが好ましい。プロティナーゼインヒビターはジャガイモからの抽出物に多く含まれることが知られている。   Examples of the “protein” include soy protein, milk protein, wheat protein, rice bran protein extract, proteinase inhibitor, etc. Among them, proteinase inhibitor is preferable. It is known that proteinase inhibitors are abundant in extracts from potatoes.

アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質は1種又は2種以上配合することができ、その配合量は、LMペクチン1質量部に対して0.01〜1.5質量部であり、0.02〜1.5質量部が好ましい。この配合割合において、飲む前は普通の水性液体飲料であるが、飲んだ後に胃の中で胃酸と反応してゲル化し、胃の中に滞留して腹持ちがよいという性質を有し、更にアミノ酸、タウリン、カルニチン、ペプチド、タンパク質を配合しても十分なゲル強度が担保された水性液体飲料を提供することができる。   Amino acid, taurine, carnitine, peptide or protein can be blended in one or more kinds, and the blending amount is 0.01-1.5 parts by mass with respect to 1 part by mass of LM pectin, 0.02 -1.5 mass parts is preferable. In this blending ratio, it is a normal aqueous liquid drink before drinking, but after drinking it has the property of reacting with stomach acid in the stomach to gel, staying in the stomach and having a good stomach, and amino acids , Taurine, carnitine, peptide, protein can be blended to provide an aqueous liquid beverage with sufficient gel strength.

本発明の水性液体飲料のpHは、LMペクチンがpH3.5未満でゲル化することから3.5〜7.0が好ましく、水性液体飲料の製造のし易さという点から、3.9〜7.0がより好ましい。   The pH of the aqueous liquid beverage of the present invention is preferably 3.5 to 7.0 because LM pectin gels when the pH is less than 3.5, and 3.9 to 3.9 from the viewpoint of easy production of the aqueous liquid beverage. 7.0 is more preferable.

本発明の水性液体飲料のpHを上記範囲に保つために、必要に応じて有機酸等のpH調整剤を配合することができる。   In order to keep the pH of the aqueous liquid beverage of the present invention in the above range, a pH adjuster such as an organic acid can be blended as necessary.

また、その他の成分として、ビタミン類、ミネラル類、生薬、生薬抽出物、カフェイン、ローヤルゼリー等を本発明の効果を損なわない範囲で適宜に配合することができる。更に必要に応じて、抗酸化剤、着色剤、香料、矯味剤、保存剤、甘味料等の添加物を本発明の効果を損なわない範囲で適宜に配合することができる。   Moreover, as other components, vitamins, minerals, herbal medicines, herbal medicine extracts, caffeine, royal jelly, and the like can be appropriately blended as long as the effects of the present invention are not impaired. Furthermore, additives such as antioxidants, colorants, fragrances, flavoring agents, preservatives, sweeteners and the like can be appropriately blended as necessary so long as the effects of the present invention are not impaired.

本発明の水性液体飲料は、常法により調製することができ、その方法は特に限定されるものではない。例えば、各成分を秤量し適量の精製水に溶解した後、pHを調整し、更に精製水を加えて容量調整し、必要に応じてろ過、殺菌処理を施すことにより調製することができる。   The aqueous liquid beverage of the present invention can be prepared by a conventional method, and the method is not particularly limited. For example, after each component is weighed and dissolved in an appropriate amount of purified water, the pH is adjusted, the volume is further adjusted by adding purified water, and filtration and sterilization are performed as necessary.

本発明の水性液体飲料は、清涼飲料水、機能性飲料の他、ドリンク剤、シロップ等の医薬品及び医薬部外品、茶飲料、スポーツドリンク等の食品領域における各種飲料として提供することができる。   The aqueous liquid drink of the present invention can be provided as various drinks in food areas such as soft drinks, functional drinks, pharmaceuticals such as drinks and syrups, quasi drugs, tea drinks, and sports drinks.

以下に実施例、比較例及び試験例を示し、本発明をより詳細に説明する。   Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples and Test Examples.

[実施例及び比較例]
精製水にクエン酸水和物及び安息香酸ナトリウムを添加し、更に、アミノ酸(グリシン;比較例3,実施例1、L−アルギニン塩酸塩;比較例5,実施例3)、タウリン(比較例4,10,11、実施例2,8〜11)、L−カルニチン(比較例9,実施例7)、ペプチド(酵母ペプチド;比較例6,実施例4、コラーゲンペプチド;比較例7,実施例5)又はタンパク質(プロティナーゼインヒビターを含有するジャガイモ抽出物;比較例8,実施例6)を添加し溶解させて、塩酸・水酸化ナトリウムでpHを3.5(最終pH3.9の場合)、4.5(最終pH4.5、7.0の場合)に調整した。該溶液を80℃に加温し、LMペクチンを溶解させ、該溶液に更にデキストリン(比較例2,実施例1〜11)、精製水を加えて全量100mLとし、水酸化ナトリウムでpHを3.9、4.5または7.0に調整した。各試験液をガラスビンに充填後殺菌し、表1〜8に示す実施例1〜11並びに比較例1〜11の飲料を得た。
[Examples and Comparative Examples]
Citric acid hydrate and sodium benzoate were added to purified water, and further amino acids (glycine; Comparative Example 3, Example 1, L-arginine hydrochloride; Comparative Example 5, Example 3), taurine (Comparative Example 4). , 10, 11, Examples 2, 8 to 11), L-carnitine (Comparative Example 9, Example 7), peptide (yeast peptide; Comparative Example 6, Example 4, collagen peptide; Comparative Example 7, Example 5) ) Or protein (potato extract containing proteinase inhibitor; Comparative Example 8, Example 6) is added and dissolved, and the pH is 3.5 with hydrochloric acid / sodium hydroxide (when the final pH is 3.9). 5 (in the case of final pH 4.5, 7.0). The solution was heated to 80 ° C. to dissolve LM pectin, and dextrin (Comparative Example 2, Examples 1 to 11) and purified water were further added to the solution to make a total volume of 100 mL, and the pH was adjusted to 3. with sodium hydroxide. Adjusted to 9, 4.5 or 7.0. Each test solution was filled in a glass bottle and sterilized to obtain beverages of Examples 1 to 11 and Comparative Examples 1 to 11 shown in Tables 1 to 8.

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

[試験例1] ゲル強度の測定
ゲル強度(破断強度)は下記の方法で測定した。
[Test Example 1] Measurement of gel strength Gel strength (breaking strength) was measured by the following method.

50mLビーカーに12.5mLの実施例1〜11並びに比較例1〜11で調製した飲料のサンプルを入れ、12.5mLの日局1液(日本薬局方崩壊試験法第1液)を壁面に沿って静かに滴下した。なお、日局1液は、胃液に相当する酸性溶液(pHは1.2)である。室温で1時間放置後、レオメーターにてゲル強度(破断強度)を測定した。   Put 12.5 mL of the beverage samples prepared in Examples 1 to 11 and Comparative Examples 1 to 11 in a 50 mL beaker, and add 12.5 mL of Japanese Pharmacopoeia 1 liquid (Japanese Pharmacopoeia Disintegration Test Method 1st liquid) along the wall surface. And dripped gently. In addition, JP 1 liquid is an acidic solution (pH is 1.2) corresponding to gastric juice. After standing at room temperature for 1 hour, the gel strength (breaking strength) was measured with a rheometer.

使用機器:FUDOH
レオメーター(レオテック製 型式:RT−2100NJ−CW)
使用アダプタ:粘弾性太丸棒φ20mm
試験モード:破断試験
測定レンジ:20N
テーブル速度:1cm/min
3回の測定結果の平均値を表5〜8に示す。
Equipment used: FUDOH
Rheometer (Rheotech model: RT-2100NJ-CW)
Adapter used: Viscoelastic thick round bar φ20mm
Test mode: Break test Measurement range: 20N
Table speed: 1 cm / min
Tables 5 to 8 show average values of the three measurement results.

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

Figure 0006441674
Figure 0006441674

比較例3〜9のようにLMペクチン及びアミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合した場合は比較例1(LMペクチンを配合し、アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合していない)に比し、ゲル強度(破断強度)が著しく低下した。一方、実施例1〜7のようにLMペクチン及びアミノ酸、タウリン、カルニチン、ペプチド又はタンパク質を配合した場合に更にデキストリンを同時配合することによって比較例3〜9に比し、ゲル強度(破断強度)が増大することがわかった。   When LM pectin and amino acid, taurine, carnitine, peptide or protein are blended as in Comparative Examples 3 to 9, Comparative Example 1 (LM Pectin is blended and amino acid, taurine, carnitine, peptide or protein is not blended) As compared with, the gel strength (breaking strength) was significantly reduced. On the other hand, when LM pectin and amino acid, taurine, carnitine, peptide or protein were blended as in Examples 1-7, the gel strength (breaking strength) was compared with Comparative Examples 3-9 by further blending dextrin. Was found to increase.

実施例8及び9のようにタウリンを配合しpH3.9〜7.0とすることで比較例10及び11に比し、ゲル強度(破断強度)が顕著に増加した。   Compared to Comparative Examples 10 and 11, gel strength (breaking strength) was remarkably increased by blending taurine as in Examples 8 and 9 and adjusting the pH to 3.9 to 7.0.

実施例10及び11のようにLMペクチン1質量部に対して、タウリン1.5質量部を配合してもデキストリンを配合することで比較例4に比し、ゲル強度(破断強度)が顕著に増加した。   As in Examples 10 and 11, the gel strength (breaking strength) is significantly higher than that in Comparative Example 4 by blending dextrin with 1.5 parts by mass of taurine per 1 part by mass of LM pectin. Increased.

本発明により、飲む前は普通の水性液体飲料であるが、飲んだ後に胃の中で胃酸と反応してゲル化し、胃の中に滞留して腹持ちがよいという性質を有し、更にアミノ酸、タウリン、カルニチン、ペプチド、タンパク質を配合した水性液体飲料を提供することが可能となった。よって、本発明を肥満予防のためのダイエットを志向した医薬品、医薬部外品及び食品として提供することにより、これらの産業の発達が期待される。   According to the present invention, it is a normal aqueous liquid drink before drinking, but after drinking, it reacts with stomach acid in the stomach and gels, has the property of staying in the stomach and having a good stomach, It has become possible to provide an aqueous liquid drink containing taurine, carnitine, peptide, and protein. Therefore, the development of these industries is expected by providing the present invention as a pharmaceutical, quasi-drug and food aimed at preventing obesity.

Claims (3)

LMペクチン、デキストリン、及びアミノ酸、タウリン、カルニチン、ペプチド又はタンパク質の1種又は2種以上を配合した水性液体飲料であり、
LMペクチンの配合量が〜3.5質量%であり、
デキストリンの配合量がLMペクチン1質量部に対して1〜100質量部であり、
アミノ酸、タウリン、カルニチン、ペプチド又はタンパク質の1種又は2種以上の配合量がLMペクチン1質量部に対して0.02〜1.5質量部であり、
pHが3.5〜7.0であり、かつ、
前記タンパク質がプロティナーゼインヒビターを含有するジャガイモ抽出物である、
ことを特徴とする水性液体飲料。
LM pectin, dextrin, and an aqueous liquid beverage formulated amino acid, taurine, carnitine, one peptide or protein, or two or more,
The amount of LM pectin is 2 to 3.5% by mass,
The amount of dextrin is 1 to 100 parts by mass with respect to 1 part by mass of LM pectin,
The amount of one or more amino acids, taurine, carnitine, peptide or protein is 0.02 to 1.5 parts by mass with respect to 1 part by mass of LM pectin,
pH is 3.5-7.0, and
The protein is a potato extract containing a proteinase inhibitor;
An aqueous liquid beverage characterized by that.
前記アミノ酸がグリシン又はアルギニンである請求項1に記載の水性液体飲料。 The aqueous liquid beverage according to claim 1, wherein the amino acid is glycine or arginine. 前記ペプチドが酵母ペプチド又はコラーゲンペプチドである請求項1に記載の水性液体飲料。
The aqueous liquid drink according to claim 1, wherein the peptide is a yeast peptide or a collagen peptide.
JP2014509183A 2012-04-04 2013-04-03 Aqueous liquid beverage Active JP6441674B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014509183A JP6441674B2 (en) 2012-04-04 2013-04-03 Aqueous liquid beverage

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012085093 2012-04-04
JP2012085093 2012-04-04
JP2014509183A JP6441674B2 (en) 2012-04-04 2013-04-03 Aqueous liquid beverage

Publications (2)

Publication Number Publication Date
JPWO2013151084A1 JPWO2013151084A1 (en) 2015-12-17
JP6441674B2 true JP6441674B2 (en) 2018-12-19

Family

ID=49300565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014509183A Active JP6441674B2 (en) 2012-04-04 2013-04-03 Aqueous liquid beverage

Country Status (7)

Country Link
JP (1) JP6441674B2 (en)
CN (1) CN104349684A (en)
HK (1) HK1206942A1 (en)
IN (1) IN2014DN08377A (en)
PH (1) PH12014502240A1 (en)
TW (1) TW201402015A (en)
WO (1) WO2013151084A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6798314B2 (en) * 2014-11-27 2020-12-09 大正製薬株式会社 Aqueous liquid beverage
WO2017126132A1 (en) * 2016-01-20 2017-07-27 Suntory Holdings Limited Collagen peptide-containing composition
JP7243157B2 (en) * 2017-12-13 2023-03-22 大正製薬株式会社 Carbonated drink
JP7408945B2 (en) * 2018-08-21 2024-01-09 大正製薬株式会社 Oral composition
JP7486019B2 (en) * 2020-03-25 2024-05-17 大正製薬株式会社 Carbonated drink

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0394655A (en) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd Nutrient feeding composition
JP4620819B2 (en) * 1999-08-25 2011-01-26 味の素株式会社 High calorie high protein liquid food
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
CN1691961A (en) * 2002-11-29 2005-11-02 森永乳业株式会社 Cysteine protease inhibitor
JP2006141258A (en) * 2004-11-18 2006-06-08 Q P Corp Liquid food and anti-vomiting food using the same
US20060204567A1 (en) * 2005-03-08 2006-09-14 Jiang Hu Potato proteinase inhibitor II exhibits activity in elevating fasting plasma cholecystokinin concentrations
MX2010004004A (en) * 2007-10-22 2010-04-30 Coca Cola Co Neutralized juice-based beverages and method of making same.
JP2009215301A (en) * 2009-04-27 2009-09-24 Morinaga Milk Ind Co Ltd Protease inhibitor
JP2010011877A (en) * 2009-10-23 2010-01-21 Tsujido Chemical Corp Food composition
JP2011147444A (en) * 2009-12-25 2011-08-04 Kaneka Corp Emulsified food composition
CN101731337B (en) * 2009-12-28 2012-05-30 内蒙古伊利实业集团股份有限公司 Yoghourt containing yeast polypeptide and production method thereof

Also Published As

Publication number Publication date
CN104349684A (en) 2015-02-11
JPWO2013151084A1 (en) 2015-12-17
HK1206942A1 (en) 2016-01-22
IN2014DN08377A (en) 2015-05-08
TW201402015A (en) 2014-01-16
PH12014502240A1 (en) 2014-12-15
WO2013151084A1 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
JP5890175B2 (en) Collagen peptide composition having high blood transferability and food and drink containing the same
JP6441674B2 (en) Aqueous liquid beverage
JP6673210B2 (en) Acidic protein drink
CN100399948C (en) Beverages containing amino acids and method for reducing the bitterness of amino acids
JP2011184314A (en) Muscular atrophy-preventing agent
JP5442510B2 (en) Beverage containing collagen peptide
Cai et al. Immune functional impacts of oyster peptide-based enteral nutrition formula (OPENF) on mice: A pilot study
JP6183355B2 (en) Aqueous liquid beverage
JP6041242B2 (en) Peptides containing tryptophan
CN102573880B (en) Fat Accumulation Inhibitor
JP6425020B2 (en) Aqueous liquid beverage
JP2016149946A (en) Beverage
JP2008148568A (en) Protein supplemental food
JP7243157B2 (en) Carbonated drink
WO2017033710A1 (en) Oral composition
KR102693582B1 (en) Hypoallergenic whey protein hydrolysate and preparation method thereof
JP2000270809A (en) healthy food
JP6137501B2 (en) Aqueous liquid beverage
JP2021073869A (en) Food and drink composition reduced in unpleasant taste
JPWO2013151080A1 (en) Aqueous liquid beverage
JPWO2016104334A1 (en) Aqueous liquid beverage
JP2017055691A (en) Beverage
HK1203321B (en) Aqueous liquid beverage

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20171003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180920

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181122

R150 Certificate of patent or registration of utility model

Ref document number: 6441674

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250